DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
-1.5%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$184M
AUM Growth
+$184M
(-7.5%)
Cap. Flow
-$9.28M
Cap. Flow
% of AUM
-5.05%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
92
New
8
Increased
20
Reduced
17
Closed
13
Top Buys
| 1 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
$1.83M |
| 2 |
argenx
ARGX
|
$1.51M |
| 3 |
Xencor
XNCR
|
$1.08M |
| 4 |
Apple
AAPL
|
$1.06M |
| 5 |
Altimmune
ALT
|
$1.06M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$5.73M |
| 2 |
KIN
Kindred Biosciences, Inc.
KIN
|
$3.32M |
| 3 |
Oracle
ORCL
|
$1.96M |
| 4 |
SPDR Gold Trust
GLD
|
$1.64M |
| 5 |
Advanced Micro Devices
AMD
|
$1.54M |
Sector Composition
| 1 | Healthcare | 46.88% |
| 2 | Technology | 14.95% |
| 3 | Communication Services | 10.39% |
| 4 | Financials | 6.61% |
| 5 | Consumer Discretionary | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.1M | 6.24% | 379,000 +4,000 | +1% | +$149K |
|
2
Micron Technology
MU
$133B
| $12.6M | 5.56% | 177,500 +7,500 | +4% | +$532K |
|
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $11.6M | 5.12% | 4,350 -2,150 | -33% | -$5.73M |
|
4
Regeneron Pharmaceuticals
REGN
$61.5B
| $9.68M | 4.27% | 16,000 +500 | +3% | +$303K |
|
5
AbbVie
ABBV
$372B
| $8.39M | 3.7% | 77,750 +750 | +1% | +$80.9K |
|
|
6
argenx
ARGX
$43.6B
| $7.55M | 3.33% | 25,000 +5,000 | +25% | +$1.51M |
|
|
7
Xencor
XNCR
$580M
| $7.51M | 3.32% | 230,000 +33,000 | +17% | +$1.08M |
|
8
Bank of America
BAC
$376B
| $6.37M | 2.81% | 150,000 | – | – |
|
9
Verizon
VZ
$186B
| $5.4M | 2.38% | 100,000 | – | – |
|
10
VanEck Gold Miners ETF
GDX
$19B
| $5.16M | 2.28% | 175,000 -10,000 | -5% | -$295K |
|
11
Turning Point Brands
TPB
$1.79B
| $4.82M | 2.13% | 101,000 -21,250 | -17% | -$1.01M |
|
12
Incyte
INCY
$16.5B
| $4.82M | 2.13% | 70,000 +9,000 | +15% | +$619K |
|
13
General Motors
GM
$55.8B
| $4.74M | 2.09% | 90,000 -10,000 | -10% | -$527K |
|
14
Citigroup
C
$178B
| $4.56M | 2.01% | 65,000 | – | – |
|
15
Prothena Corp
PRTA
$441M
| $4.27M | 1.89% | 60,000 -1,750 | -3% | -$125K |
|
|
16
Advanced Micro Devices
AMD
$264B
| $4.12M | 1.82% | 40,000 -15,000 | -27% | -$1.54M |
|
|
17
SPDR Gold Trust
GLD
$107B
| $3.7M | 1.63% | 22,500 -10,000 | -31% | -$1.64M |
|
|
18
Oracle
ORCL
$635B
| $3.49M | 1.54% | 40,000 -22,500 | -36% | -$1.96M |
|
19
iShares Gold Trust
IAU
$50.6B
| $3.34M | 1.47% | 100,000 | – | – |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.3M | 1.46% | 17,500 | – | – |
|
21
Pfizer
PFE
$141B
| $2.8M | 1.23% | 65,000 | – | – |
|
|
22
Altimmune
ALT
$338M
| $2.71M | 1.19% | 239,200 +93,450 | +64% | +$1.06M |
|
23
Eli Lilly
LLY
$657B
| $2.6M | 1.15% | 11,250 | – | – |
|
|
AOD
24
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.52M | 1.11% | 259,000 -11,000 | -4% | -$107K |
|
25
Amgen
AMGN
$155B
| $2.39M | 1.06% | 11,250 | – | – |
|